Intravenous peramivir vs oral oseltamivir in high‐risk emergency department patients with influenza: Results from a pilot randomized controlled study

BACKGROUND: Peramivir offers a single‐dose intravenous (IV) treatment option for influenza (vs 5‐day oral dosing for oseltamivir). We sought to compare outcomes of emergency department (ED) patients at high risk for influenza complications treated with IV peramivir vs oral oseltamivir. METHODS: Duri...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsieh, Yu‐Hsiang, Dugas, Andrea F., LoVecchio, Frank, McBryde, Breana, Ricketts, Erin P., Saliba‐Shaw, Kathryn, Rothman, Richard E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767951/
https://www.ncbi.nlm.nih.gov/pubmed/33006445
http://dx.doi.org/10.1111/irv.12794

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767951/
https://www.ncbi.nlm.nih.gov/pubmed/33006445
http://dx.doi.org/10.1111/irv.12794

Ejemplares similares